BACKGROUND: Stroke is one of the leading complications during continuous flow-left ventricular assist device (CF-LVAD) support. Risk factors have been well described, although less is known regarding treatment and outcomes. We present a large single-center experience on stroke outcome and transplant eligibility by stroke sub-type and severity in CF-LVAD patients. METHODS: Between January 1, 2008, and April 1, 2015, 301 patients underwent CF-LVAD (266 HeartMate II [HM I], Thoratec Corp, Pleasanton, CA; 35 HeartWare [HVAD], HeartWare International Inc, Framingham, MA). Stroke was defined as a focal neurologic deficit with abnormal neuroimaging. Intracerebral hemorrhage (ICH) definition excluded sub-dural hematoma and hemorrhagic conversion of an ischemic stroke (IS). Treatment in IS included intra-arterial embolectomy when appropriate; treatment in ICH included reversal of coagulopathy. Stroke severity was measured using the National Institutes of Health Stroke Scale (NIHSS). Outcomes were in-hospital mortality and transplant status. RESULTS: Stroke occurred in 40 patients: 8 ICH (4 HM II, 4 HVAD) and 32 IS (26 HM II, 6 HVAD). Among 8 ICH patients, there were 4 deaths (50%), with NIHSS of 18.8 ± 13.7 vs 1.8 ± 1.7 in survivors (p = 0.049). Among 32 IS patients, 12 had hemorrhagic conversion and 5 were treated with intra-arterial embolectomy. There were 9 deaths (28%), with NIHSS of 16.2 ± 10.8 vs 7.0 ± 7.6 in survivors (p = 0.011). Among the 32 IS patients, 12 underwent transplant, and 1 is awaiting transplant. No ICH patients received a transplant. CONCLUSIONS: In-hospital mortality after stroke is significantly affected by the initial neurologic impairment. Patients with IS appear to benefit the most from in-hospital treatment and often make sufficient recovery to be able to progress to transplant.
BACKGROUND:Stroke is one of the leading complications during continuous flow-left ventricular assist device (CF-LVAD) support. Risk factors have been well described, although less is known regarding treatment and outcomes. We present a large single-center experience on stroke outcome and transplant eligibility by stroke sub-type and severity in CF-LVADpatients. METHODS: Between January 1, 2008, and April 1, 2015, 301 patients underwent CF-LVAD (266 HeartMate II [HM I], Thoratec Corp, Pleasanton, CA; 35 HeartWare [HVAD], HeartWare International Inc, Framingham, MA). Stroke was defined as a focal neurologic deficit with abnormal neuroimaging. Intracerebral hemorrhage (ICH) definition excluded sub-dural hematoma and hemorrhagic conversion of an ischemic stroke (IS). Treatment in IS included intra-arterial embolectomy when appropriate; treatment in ICH included reversal of coagulopathy. Stroke severity was measured using the National Institutes of Health Stroke Scale (NIHSS). Outcomes were in-hospital mortality and transplant status. RESULTS:Stroke occurred in 40 patients: 8 ICH (4 HM II, 4 HVAD) and 32 IS (26 HM II, 6 HVAD). Among 8 ICHpatients, there were 4 deaths (50%), with NIHSS of 18.8 ± 13.7 vs 1.8 ± 1.7 in survivors (p = 0.049). Among 32 IS patients, 12 had hemorrhagic conversion and 5 were treated with intra-arterial embolectomy. There were 9 deaths (28%), with NIHSS of 16.2 ± 10.8 vs 7.0 ± 7.6 in survivors (p = 0.011). Among the 32 IS patients, 12 underwent transplant, and 1 is awaiting transplant. No ICHpatients received a transplant. CONCLUSIONS: In-hospital mortality after stroke is significantly affected by the initial neurologic impairment. Patients with IS appear to benefit the most from in-hospital treatment and often make sufficient recovery to be able to progress to transplant.
Authors: James K Kirklin; David C Naftel; Francis D Pagani; Robert L Kormos; Lynne W Stevenson; Elizabeth D Blume; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young Journal: J Heart Lung Transplant Date: 2014-04-21 Impact factor: 10.247
Authors: James K Kirklin; David C Naftel; Robert L Kormos; Francis D Pagani; Susan L Myers; Lynne W Stevenson; Michael A Acker; Daniel L Goldstein; Scott C Silvestry; Carmelo A Milano; J T Baldwin; J Timothy Baldwin; Sean Pinney; J Eduardo Rame; Marissa A Miller Journal: J Heart Lung Transplant Date: 2013-11-27 Impact factor: 10.247
Authors: Laura Harvey; Christopher Holley; Samit S Roy; Peter Eckman; Rebecca Cogswell; Kenneth Liao; Ranjit John Journal: Ann Thorac Surg Date: 2015-06-09 Impact factor: 4.330
Authors: Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo Journal: Stroke Date: 2010-07-22 Impact factor: 7.914
Authors: Frank L Dini; Ryan T Demmer; Anca Simioniuc; Doralisa Morrone; Francesca Donati; Giacinta Guarini; Enrico Orsini; Paolo Caravelli; Mario Marzilli; Paolo C Colombo Journal: Eur J Heart Fail Date: 2012-03 Impact factor: 15.534
Authors: Thomas J Wilson; William R Stetler; Wajd N Al-Holou; Stephen E Sullivan; Jeffrey J Fletcher Journal: J Neurosurg Date: 2013-03-01 Impact factor: 5.115
Authors: Jeffrey A Morgan; Robert J Brewer; Hassan W Nemeh; Brent Gerlach; David E Lanfear; Celeste T Williams; Gaetano Paone Journal: ASAIO J Date: 2014 May-Jun Impact factor: 2.872
Authors: Ronald M Lazar; Peter A Shapiro; Brian E Jaski; Michael K Parides; Robert C Bourge; John T Watson; Laura Damme; Walter Dembitsky; Jeffrey D Hosenpud; Lopa Gupta; Anita Tierney; Tonya Kraus; Yoshifumi Naka Journal: Circulation Date: 2004-05-03 Impact factor: 29.690
Authors: Muhammad Shahreyar; Tamunoinemi Bob-Manuel; Rami N Khouzam; Mohammad W Bashir; Samian Sulaiman; Oluwaseun Akinseye; Arindam Sharma; April Carter; Samuel Latham; Sanjay Bhandari; Arshad Jahangir Journal: Ann Transl Med Date: 2018-01
Authors: Francesco Castagna; Eric J Stöhr; Alberto Pinsino; John R Cockcroft; Joshua Willey; A Reshad Garan; Veli K Topkara; Paolo C Colombo; Melana Yuzefpolskaya; Barry J McDonnell Journal: Curr Hypertens Rep Date: 2017-10-18 Impact factor: 5.369
Authors: Claudio A Bravo; Justin A Fried; Joshua Z Willey; Azka Javaid; Giulio M Mondellini; Lorenzo Braghieri; Heidi Lumish; Veli K Topkara; Yuji Kaku; Lucas Witer; Hiroo Takayama; Koji Takeda; Gabriel Sayer; Nir Uriel; Ryan T Demmer; Yoshifumi Naka; Melana Yuzefpolskaya; Paolo C Colombo Journal: J Card Fail Date: 2021-06-20 Impact factor: 5.712
Authors: Laura Stein; Alison Thaler; John W Liang; Stanley Tuhrim; Amit S Dhamoon; Mandip S Dhamoon Journal: J Am Heart Assoc Date: 2017-12-02 Impact factor: 5.501